I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Recombinant Haemagglutinin Derived From the Ciliated Protoz..:
Karina Jawinski
;
Marcus Hartmann
;
Charanjit Singh
...
https://www.frontiersin.org/article/10.3389/fimmu.2019.02661/full. , 2019
Link:
https://doi.org/10.3389/fimmu.2019.02661
RT Journal T1
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:09463d6bdf634220b38f8e9744e2fabe&Exemplar=1&LAN=DE A1 Karina Jawinski A1 Marcus Hartmann A1 Charanjit Singh A1 Ekaterina Kinnear A1 David C. Busse A1 Annalisa Ciabattini A1 Fabio Fiorino A1 Donata Medaglini A1 Claudia Maria Trombetta A1 Emanuele Montomoli A1 Vanessa Contreras A1 Roger Le Grand A1 Celine Coiffier A1 Charlotte Primard A1 Bernard Verrier A1 John S. Tregoning PB Frontiers Media S.A. YR 2019 K1 influena virus K1 protozoa K1 adjuvant K1 nanoparticle K1 vaccine manufacture K1 Immunologic diseases. Allergy K1 RC581-607 JF https://www.frontiersin.org/article/10.3389/fimmu.2019.02661/full LK http://dx.doi.org/https://doi.org/10.3389/fimmu.2019.02661 DO https://doi.org/10.3389/fimmu.2019.02661 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)